Product Name

  • Name

    Acetazolamide

  • EINECS 200-440-5
  • CAS No. 59-66-5
  • Article Data24
  • CAS DataBase
  • Density 1.744 g/cm3
  • Solubility <0.1 g/100 mL at 22 °C in water
  • Melting Point 256-261 °C
  • Formula C4H6N4O3S2
  • Boiling Point
  • Molecular Weight 222.249
  • Flash Point
  • Transport Information UN 2811
  • Appearance White to yellowish-white fine crystalline powder
  • Safety 26-36
  • Risk Codes 36/38-36/37/38
  • Molecular Structure Molecular Structure of 59-66-5 (Acetazolamide)
  • Hazard Symbols IrritantXi
  • Synonyms Acetamide, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)- (8CI);2-Acetamido-1,3,4-thiadiazole-5-sulfonamide;2-Acetylamino-1,3,4-thiadiazole-5-sulfonamide;5-Acetamide-1,3,4-thiadiazole-2-sulfonamide;5-Acetylamino-1,3,4-thiadiazol-2-ylsulfonamide;Acetamox;Acetazolamid;Acetazolamide;Atenezol;Cidamex;Diakarb;Diamox;Diluran;Diuramide;Diuriwas;Diutazol;Eumicton;Glaupax;L 579486;N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide;N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide;NSC 145177;Natrionex;Phonurit;
  • PSA 151.66000
  • LogP 0.99800

Synthetic route

5-amino-1, 3, 4-thiadiazole-2-sulfonamide
14949-00-9

5-amino-1, 3, 4-thiadiazole-2-sulfonamide

thioacetic acid
507-09-5

thioacetic acid

acetazolamide
59-66-5

acetazolamide

Conditions
ConditionsYield
With 10-methyl-9-(2,4,6-trimethylphenyl) acridinium tetrafluoroborate In acetonitrile at 20℃; for 5h; Irradiation;76%
5-acetamido-1,3,4-thiadiazolyl-2-sulfonyl chloride
32873-57-7

5-acetamido-1,3,4-thiadiazolyl-2-sulfonyl chloride

acetazolamide
59-66-5

acetazolamide

Conditions
ConditionsYield
With 1,1,1-triphenylsilylamine In acetonitrile for 1h; Reflux; Inert atmosphere;74%
With ammonium hydroxide In water for 1h; Cooling with ice;72%
With ammonium hydroxide at 20℃; for 0.5h;46%
2-acetylamino-5-benzylmercapto-1,3,4-thiadiazole
64387-67-3

2-acetylamino-5-benzylmercapto-1,3,4-thiadiazole

acetazolamide
59-66-5

acetazolamide

Conditions
ConditionsYield
With chlorine; acetic acid anschliessendes Behandeln mit fluessigem NH3;
Stage #1: 2-acetylamino-5-benzylmercapto-1,3,4-thiadiazole With chlorine; acetic acid at 50℃; for 0.5h;
Stage #2: With ammonia
Stage #1: 2-acetylamino-5-benzylmercapto-1,3,4-thiadiazole With water; chlorine; acetic acid at 5℃; for 0.5h;
Stage #2: With ammonia

A

acetazolamide
59-66-5

acetazolamide

B

C20H25NO5
68905-61-3

C20H25NO5

Conditions
ConditionsYield
With water at 37℃; pH=7.4;
PMA

PMA

A

acetazolamide
59-66-5

acetazolamide

B

C20H23NO5
687620-14-0

C20H23NO5

Conditions
ConditionsYield
With water at 37℃; pH=7.4;

A

acetazolamide
59-66-5

acetazolamide

B

C24H25NO5

C24H25NO5

Conditions
ConditionsYield
With water at 37℃; pH=7.4;
succinic acid anhydride
108-30-5

succinic acid anhydride

acetazolamide
59-66-5

acetazolamide

acetazolamide
59-66-5

acetazolamide

5-amino-1, 3, 4-thiadiazole-2-sulfonamide
14949-00-9

5-amino-1, 3, 4-thiadiazole-2-sulfonamide

Conditions
ConditionsYield
With hydrogenchloride In ethanol for 4h; Reflux;100%
With hydrogenchloride In methanol; water for 18h; Reflux;98%
With hydrogenchloride; water In methanol for 18h; Reflux;98%
acetazolamide
59-66-5

acetazolamide

Acetazolamide sodium salt

Acetazolamide sodium salt

Conditions
ConditionsYield
With sodium hydroxide In water at 55℃; for 2h;99%
acetazolamide
59-66-5

acetazolamide

cobalt(II) chloride
7646-79-9

cobalt(II) chloride

Co(5-acetamido-1,3,4-thiadiazole-2-sulphonamide)2(NH3)2

Co(5-acetamido-1,3,4-thiadiazole-2-sulphonamide)2(NH3)2

Conditions
ConditionsYield
With NH3 In ethanol addn. of the ligand to a soln. of CoCl2 in ethanol, warming, stirring, addn. of NH3; filtn. of ppt., washing (EtOH), dried at 40 °C, elem. anal.;98%
acetazolamide
59-66-5

acetazolamide

5-amino-2-sulfamoyl-1,3,4-thiadiazole monohydrochloride
120208-98-2

5-amino-2-sulfamoyl-1,3,4-thiadiazole monohydrochloride

Conditions
ConditionsYield
With hydrogenchloride for 3h; Reflux;96%
With hydrogenchloride In water for 3h; Reflux;96%
With hydrogenchloride for 3h; Reflux;96%
With hydrogenchloride In ethanol for 3h; Inert atmosphere; Reflux;65%
With hydrogenchloride; water at 60℃; for 2h; Heating / reflux;
acetazolamide
59-66-5

acetazolamide

zinc(II) chloride
7646-85-7

zinc(II) chloride

Zn(5-acetamido-1,3,4-thiadiazole-2-sulphonamide)2(NH3)2

Zn(5-acetamido-1,3,4-thiadiazole-2-sulphonamide)2(NH3)2

Conditions
ConditionsYield
With NH3 In methanol addn. of NH3 to a soln. of ligand in methanol, addn. of ZnCl2, stirring, pptn. on standing at room temp. for 3 h; filtn., washing (water), drying at 60°C, elem. anal.;96%
acetazolamide
59-66-5

acetazolamide

Trimethylenediamine
109-76-2

Trimethylenediamine

copper(ll) bromide
7789-45-9

copper(ll) bromide

bis(5-acetamidato-1,3,4-thiadiazole-2-sulfonamide-N)bis(1,3-propanediamine)copper(II)

bis(5-acetamidato-1,3,4-thiadiazole-2-sulfonamide-N)bis(1,3-propanediamine)copper(II)

Conditions
ConditionsYield
In ethanol solid ligand was dissolved in hot soln. of CuBr2 in EtOH with heating and stirring, propanediamine was added dropwise with stirring; soln. was stored at 4°C for 3-4 d, crystals were collected, elem. anal.;90%
[ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2
52462-29-0

[ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2

acetazolamide
59-66-5

acetazolamide

[(η6-p-cymene)RuCl2(κN11-AcmH2)]

[(η6-p-cymene)RuCl2(κN11-AcmH2)]

Conditions
ConditionsYield
In acetone for 7h; Reflux;90%
In acetone at 20℃; for 12h; Temperature;47%
acetazolamide
59-66-5

acetazolamide

5-amino-2-sulfonamido-1,3,4-thiadiazole

5-amino-2-sulfonamido-1,3,4-thiadiazole

Conditions
ConditionsYield
In methanol; chloroform87%
In methanol; chloroform87%
zinc(II) perchlorate

zinc(II) perchlorate

acetazolamide
59-66-5

acetazolamide

Zn{C2N2S(SO2NH)(NHCOCH3)}2(NH3)2
109751-05-5

Zn{C2N2S(SO2NH)(NHCOCH3)}2(NH3)2

Conditions
ConditionsYield
With NH3 In ammonia NH3 (liquid); dissolving of the ligand and the Zn-salt in NH3, dropwise combining of the both soln.; slow evapn. of NH3 for 2 months;87%
[ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2
52462-29-0

[ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2

acetazolamide
59-66-5

acetazolamide

[(η6-p-cymene)RuCl(κ2N8,N10-acetazolamide)]

[(η6-p-cymene)RuCl(κ2N8,N10-acetazolamide)]

Conditions
ConditionsYield
With sodium hydroxide In methanol; water at 20℃; for 16h;86%
acetazolamide
59-66-5

acetazolamide

C21H24ClNO6
1373769-10-8

C21H24ClNO6

C25H29N5O9S2
1338056-91-9

C25H29N5O9S2

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;82%
acetazolamide
59-66-5

acetazolamide

C24H30ClNO6
1373769-14-2

C24H30ClNO6

C28H35N5O9S2
1338056-94-2

C28H35N5O9S2

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;82%
acetazolamide
59-66-5

acetazolamide

C25H33ClN4O6
1373769-15-3

C25H33ClN4O6

C29H38N8O9S2
1338056-97-5

C29H38N8O9S2

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;81%
acetazolamide
59-66-5

acetazolamide

C21H24ClNO6S

C21H24ClNO6S

C25H29N5O9S3

C25H29N5O9S3

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;81%
acetazolamide
59-66-5

acetazolamide

3-methoxy-2-hydroxybenzaldehyde
148-53-8

3-methoxy-2-hydroxybenzaldehyde

C12H12N4O5S2

C12H12N4O5S2

Conditions
ConditionsYield
In water for 0.0416667h; Time; Microwave irradiation; Green chemistry;79%
acetazolamide
59-66-5

acetazolamide

C24H28ClNO6
1373769-20-0

C24H28ClNO6

C28H33N5O9S2

C28H33N5O9S2

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;78%
(tris(3-cumenyl-5-methylpyrazolyl)borate)ZnOH

(tris(3-cumenyl-5-methylpyrazolyl)borate)ZnOH

acetazolamide
59-66-5

acetazolamide

ZnB(C3HN2(CH3)(C6H4CH(CH3)2))3((HNSO2)C2N2S(NHC(O)CH3))*2CH3OH

ZnB(C3HN2(CH3)(C6H4CH(CH3)2))3((HNSO2)C2N2S(NHC(O)CH3))*2CH3OH

Conditions
ConditionsYield
In methanol; dichloromethane; water stirred at room temp. for 1 d in a solvent mixture of CH2Cl2/CH3OH/H2O=10/8/3; solvent removed in vac.; recrystd. (methanol) at -25°C; elem. anal.;76%
acetazolamide
59-66-5

acetazolamide

C24H30ClNO6S
1373769-16-4

C24H30ClNO6S

C28H35N5O9S3
1338057-00-3

C28H35N5O9S3

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;75%
acetazolamide
59-66-5

acetazolamide

C30H31ClN2O6
1373769-43-7

C30H31ClN2O6

C34H36N6O9S2
1338057-17-2

C34H36N6O9S2

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;75%
acetazolamide
59-66-5

acetazolamide

C20H22ClNO4

C20H22ClNO4

PMA

PMA

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 8℃; pH=7 - 9.5;70%
acetazolamide
59-66-5

acetazolamide

C22H26ClNO7
1373769-21-1

C22H26ClNO7

C26H31N5O10S2
1338057-08-1

C26H31N5O10S2

Conditions
ConditionsYield
With sodium hydroxide at 8℃; pH=8.5 - 9.5;68%
acetazolamide
59-66-5

acetazolamide

C20H24ClNO4

C20H24ClNO4

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 8℃; pH=7 - 9.5;65%
copper(II) perchlorate hexahydrate

copper(II) perchlorate hexahydrate

acetazolamide
59-66-5

acetazolamide

[Co(diethylenetriamine)(acetazolamidato)]ClO4 * H2O

[Co(diethylenetriamine)(acetazolamidato)]ClO4 * H2O

Conditions
ConditionsYield
With NaOH; diethylenetriamine In methanol addn. of stoich. amt. of acetazolamide soln. contg. 1 equiv. of NaOH to Cu(ClO4)2, stirring (several min), dropwise addn. of diethylenetriamine,(stirring, pptn.); filtration, washing (MeOH), drying; elem. anal.;62%
acetazolamide
59-66-5

acetazolamide

copper(II) nitrate

copper(II) nitrate

ethylenediamine
107-15-3

ethylenediamine

bis(5-acetamidato-1,3,4-thiadiazole-2-sulfonamide-O)bis(1,2-ethanediamine)copper(II)

bis(5-acetamidato-1,3,4-thiadiazole-2-sulfonamide-O)bis(1,2-ethanediamine)copper(II)

B

bis(5-acetamidato-1,3,4-thiadiazole-2-sulfonamide)bis(1,2-ethanediamine)copper(II)

bis(5-acetamidato-1,3,4-thiadiazole-2-sulfonamide)bis(1,2-ethanediamine)copper(II)

Conditions
ConditionsYield
In ethanol heated, stirred, ethanediamine was added dropwise with stirring; filtered (violet product), soln. was stored at room temp. for 4-24 h, crystals (purple) were collected, elem. anal.;A 60%
B 30%
acetazolamide
59-66-5

acetazolamide

C24H24ClNO4

C24H24ClNO4

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 8℃; pH=7 - 9.5;55%
acetazolamide
59-66-5

acetazolamide

salicylaldehyde
90-02-8

salicylaldehyde

C11H10N4O4S2
1167412-20-5

C11H10N4O4S2

Conditions
ConditionsYield
In methanol; water for 4h; Reflux;54%
In methanol; water for 4h; Reflux;
acetazolamide
59-66-5

acetazolamide

propargyl bromide
106-96-7

propargyl bromide

5-N-(prop-2-yn-1-yl)acetamido-1,3,4-thiadiazole-2-sulfonamide

5-N-(prop-2-yn-1-yl)acetamido-1,3,4-thiadiazole-2-sulfonamide

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 16h;45.3%
zinc perchlorate

zinc perchlorate

acetazolamide
59-66-5

acetazolamide

1,5,9-triazacyclododecane
294-80-4

1,5,9-triazacyclododecane

NHS(O)2C2N2SNHC(O)CH3Zn(NH(CH2)3)3(1+)*ClO4(1-)={(C4H5N4O3S2)Zn(NH(CH2)3)3}(ClO4)

NHS(O)2C2N2SNHC(O)CH3Zn(NH(CH2)3)3(1+)*ClO4(1-)={(C4H5N4O3S2)Zn(NH(CH2)3)3}(ClO4)

Conditions
ConditionsYield
In acetonitrile dropwise addn. of soln. of Zn(ClO4)2*6H20 and acetazolamide to soln. of (12)aneN3 in MeCN; filtration, crystn. on evapn. (slow, room temp.); elem. anal.;40%

Acetazolamide Consensus Reports

Reported in EPA TSCA Inventory.

Acetazolamide Specification

The Acetazolamide has the cas register number 59-66-5, and its IUPAC name is N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide. It belongs to the product category which is Miscellaneous Enzyme.
This is a kind of white to yellowish-white fine crystalline powder with no odor or taste. Besides, it is slightly soluble in water, ethanol, nearly insoluble in chloroform and ethyl ether, and easily soluble in ammonia solution.

The characteristics of this chemical are as follows: (1)ACD/LogP: -0.26; (2)ACD/LogD (pH 5.5): -0.26; (3)ACD/LogD (pH 7.4): -0.48; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 17.06; (7)ACD/KOC (pH 7.4): 10.47; (8)#H bond acceptors: 7; (9)#H bond donors: 3; (10)#Freely Rotating Bonds: 1; (11)Polar Surface Area: 120.09; (12)Index of Refraction: 1.64; (13)Molar Refractivity: 45.95 cm3; (14)Molar Volume: 127.3 cm3; (15)Polarizability: 18.21 ×10-24 cm3; (16)Surface Tension: 97.9 dyne/cm; (17)Density: 1.744 g/cm3.

The production method of Acetazolamide: It could be produce from the amination. Firstly, mix the ammonia water and trash ice till the temperature cools to below 5℃, and then add oxychloride to have heat preservation reation for about half an hour; Secondly, adjust PH to 5-6 with hydrochloric acid and then filter with filter cake to have the PH7, and then dry to get the acetazolamide crude products; Thirdly, heat the mixture of crude products, water, activated carbon and Na2S2O5 to 95℃, and then go through the decoloration for 1-1.5hour to get crystal after filtering and cooling; Lastly, have a listing process of filtering, washing and drying to get the products.

Use of Acetazolamide: Acetazolamide reacts to produce 5-amino-[1,3,4]thiadiazole-2-sulfonic acid amide, with the following condition: reagent: HCL (37 percent); reaction time: 2 hours; yield: 2.75g; other condition: heating.

As to its usage, it is widely applied in pharmeceutics. It is a kind of diuretic, and also as carbonic anhydrase inhibitor to resist carbonic anhydrase in kidney tubules epithelial cell; It has the function of controlling Aqueous Humour secretion to release the intraocular tension, which could be applied in curing glaucoma and mild cardiac edema.

In addition, you could obtain the molecular structure by converting the following datas:
(1)SMILES:O=S(=O)(c1nnc(s1)NC(=O)C)N
(2)InChI:InChI=1/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)
(3)InChIKey:BZKPWHYZMXOIDC-UHFFFAOYAA

Below are the toxicity information of this chemical:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous > 2gm/kg (2000mg/kg)   Drugs in Japan Vol. 6, Pg. 15, 1982.
guinea pig LD50 subcutaneous > 1500mg/kg (1500mg/kg)   Drugs in Japan Vol. 6, Pg. 15, 1982.
man TDLo oral 54mg/kg/5D-I (54mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA Archives of Internal Medicine. Vol. 143, Pg. 1278, 1983.
mouse LD50 intraperitoneal 1175mg/kg (1175mg/kg)   Russian Pharmacology and Toxicology Vol. 39, Pg. 255, 1976.
mouse LD50 intravenous > 3gm/kg (3000mg/kg)   Drugs in Japan Vol. 6, Pg. 15, 1982.
mouse LD50 oral 4300mg/kg (4300mg/kg)   Acta Biologica et Medica Germanica. Vol. 21, Pg. 193, 1968.
 
mouse LD50 subcutaneous > 3gm/kg (3000mg/kg)   Drugs in Japan Vol. 6, Pg. 15, 1982.
rat LD50 intraperitoneal 2750mg/kg (2750mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 56(4), Pg. 134S, 1960

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View